Who is sponsoring NCT02056145?

NCT02056145 is sponsored by University Hospital, Antwerp.

What condition does NCT02056145 study?

NCT02056145 studies -Postoperative Pain.

What drugs are being tested in NCT02056145?

Interventions: LFCNB, FNB, LFCNB, FNB.

What is the status of NCT02056145?

NCT02056145 is currently UNKNOWN.

Last reviewed 2014-07-01 · How we verify

Ultrasound Guided Lateral Femoral Cutaneous Block (LFCNB) And Femoral Nerve Block (FNB) For Postoperative Pain Control After Hip Surgery

NCT02056145 NA UNKNOWN

Evaluation of the combination of lateral femoral cutaneous nerve "single shot" and femoral nerve "single shot" block as effective and safe alternative postoperative analgesic technique after hip replacement surgery.

Details

Lead sponsor	University Hospital, Antwerp
Phase	NA
Status	UNKNOWN
Enrolment	210
Start date	2011-10
Completion	2014-08

Conditions

-Postoperative Pain

Interventions

LFCNB
FNB
LFCNB
FNB

Primary outcomes

Use of opioids — 48 hours
The primary outcome measure will be a consumption of opioids through the Intravenous Patient Controlled Analgesia pump. Those amounts will be measured en documented at the fixed intervals during the first 48 hours post-procedure.

Countries

Belgium